⌘K

Login Start Free

Home/Filings/4/0001493152-23-023015

4//SEC Filing

Trieu Vuong 4

Accession 0001493152-23-023015

CIK 0000908259other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 9:25 AM ET

Size

7.8 KB

Accession

0001493152-23-023015

Insider Transaction Report

Form 4

Period: 2023-06-28

Oncotelic Therapeutics, Inc.OTLC

DirectorCHAIRMAN AND CEO10% Owner

Transactions

Purchase
Common Stock
2023-06-29$0.02/sh+425,000$8,925→ 92,044,217 total
Purchase
Common Stock
2023-06-28$0.03/sh+75,000$1,950→ 91,619,217 total

Holdings

Common Stock
(indirect: By Autotelic, Inc.)
16,780,384
Common Stock
(indirect: By Spouse)
6,872,529

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncotelic Therapeutics, Inc.

CIK 0000908259

Entity typeother

Related Parties

1

filerCIK 0001587074

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 9:25 AM ET
Size: 7.8 KB

View on SEC.gov